Skip to content
People

Russel Hayward

Chief Executive Officer at Etira.

Earliest Form D on file: May 2026

Filed May 14, 2026

Etira

Oral small-molecule drugs for therapy-resistant cancers

Biotech, Dallas TX

Signed as Chief Executive Officer

$2.3M

sold of $3M offered

Form D

LinkedIn

Network

At Etira

4 people